Download PDF
J Pediatr Genet 2017; 06(03): 191-193
DOI: 10.1055/s-0037-1599148
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Hyperphosphatasia with Mental Retardation Syndrome Due to a Novel Mutation in PGAP3

Sheela Nampoothiri
1   Department of Pediatric Genetics, Amrita Institute of Medical Sciences and Research Centre, Ponekkara, Cochin, Kerala, India
,
Malavika Hebbar
2   Department of Medical Genetics, Kasturba Medical College, Manipal University, Manipal, India
,
Arun Grace Roy
3   Department of Pediatric Neurology, Amrita Institute of Medical Sciences and Research Centre, Ponekkara, Cochin, Kerala, India
,
Sheena P. Kochumon
1   Department of Pediatric Genetics, Amrita Institute of Medical Sciences and Research Centre, Ponekkara, Cochin, Kerala, India
,
Stephanie Bielas
4   Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, United States
,
Anju Shukla
2   Department of Medical Genetics, Kasturba Medical College, Manipal University, Manipal, India
,
Katta M. Girisha
2   Department of Medical Genetics, Kasturba Medical College, Manipal University, Manipal, India
› Author Affiliations
Further Information

Publication History

16 November 2016

16 January 2017

Publication Date:
07 March 2017 (online)

    Permissions and Reprints

Abstract

Hyperphosphatasia with mental retardation syndrome is a heterogeneous genetic condition. Two siblings aged 5 years and 3 years were evaluated for global development delay and facial dysmorphism. A novel missense variant, c.851A>G (p.H284R, NM_033419.3), in PGAP3 was identified using whole-exome sequencing. Assays for elevated alkaline phosphatase and exome sequencing can be useful for the diagnosis of hyperphosphatasia with mental retardation syndrome.

Keywords

hyperphosphatasia with mental retardation syndrome - PGAP3 - exome sequencing - alkaline phosphatase

Note

A. S. and M. H. drafted the manuscript and analyzed the exome sequencing data. S. N. and A. G. R. are the clinicians involved in the evaluation of the patient. S. P. K. evaluated the patients and did literature search. S. B. and K. M. G. supervised the entire work. All contributors have read and approved the manuscript.


 

  • References

  • 1 Chiyonobu T, Inoue N, Morimoto M, Kinoshita T, Murakami Y. Glycosylphosphatidylinositol (GPI) anchor deficiency caused by mutations in PIGW is associated with West syndrome and hyperphosphatasia with mental retardation syndrome. J Med Genet 2014; 51 (03) 203-207
    CrossrefPubMedGoogle Scholar
  • 2 Krawitz PM, Murakami Y, Hecht J. , et al. Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation. Am J Hum Genet 2012; 91 (01) 146-151
    CrossrefPubMedGoogle Scholar
  • 3 Krawitz PM, Schweiger MR, Rödelsperger C. , et al. Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet 2010; 42 (10) 827-829
    CrossrefPubMedGoogle Scholar
  • 4 Hansen L, Tawamie H, Murakami Y. , et al. Hypomorphic mutations in PGAP2, encoding a GPI-anchor-remodeling protein, cause autosomal-recessive intellectual disability. Am J Hum Genet 2013; 92 (04) 575-583
    CrossrefPubMedGoogle Scholar
  • 5 Knaus A, Awaya T, Helbig I. , et al. Rare noncoding mutations extend the mutational spectrum in the PGAP3 subtype of hyperphosphatasia with mental retardation syndrome. Hum Mutat 2016; 37 (08) 737-744
    CrossrefPubMedGoogle Scholar
  • 6 Howard MF, Murakami Y, Pagnamenta AT. , et al. Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation. Am J Hum Genet 2014; 94 (02) 278-287
    CrossrefPubMedGoogle Scholar
  • 7 Ilkovski B, Pagnamenta AT, O'Grady GL. , et al. Mutations in PIGY: expanding the phenotype of inherited glycosylphosphatidylinositol deficiencies. Hum Mol Genet 2015; 24 (21) 6146-6159
    CrossrefPubMedGoogle Scholar